The Children's Hospital of Philadephia
Welcome,         Profile    Billing    Logout  
 1 Trial 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kwiatkowski, Janet
HOPE Kids 2, NCT04218084 / 2017-000903-26: Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell Disease

Active, not recruiting
3
236
Europe, US, RoW
Voxelotor, Placebo
Pfizer
Sickle Cell Disease
08/23
01/25
003SCD101, NCT03653247: A Study to Assess the Safety, Tolerability, and Efficacy of BIVV003 for Autologous Hematopoietic Stem Cell Transplantation in Patients With Severe Sickle Cell Disease

Checkmark Initial data from PRECIZN-1 trial for autologous hematopoietic stem cell transplantation in patients with severe sickle cell disease at ASH 2021
Nov 2021 - Nov 2021: Initial data from PRECIZN-1 trial for autologous hematopoietic stem cell transplantation in patients with severe sickle cell disease at ASH 2021
Checkmark Initial data from PRECIZN-1 trial for sickle cell disease
Mar 2021 - Mar 2021: Initial data from PRECIZN-1 trial for sickle cell disease
Active, not recruiting
1/2
8
US
Plerixafor, Busulfan, BIVV003, Autologous CD34 + hematopoietic stem cells
Sangamo Therapeutics
Sickle Cell Disease
07/25
07/25
NCT06364774: ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia

Recruiting
1/2
12
US
ALS20
Children's Hospital of Philadelphia
Beta-Thalassemia
12/27
12/27

Download Options